Hereditary angio-oedema

[1]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[2]  M. Cicardi,et al.  Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21‐month prospective study in a cohort of 103 patients , 2011, Allergy.

[3]  J. Nuijens,et al.  Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.

[4]  A. Sheffer,et al.  Ecallantide for the treatment of acute attacks in hereditary angioedema. , 2010, The New England journal of medicine.

[5]  William H. Yang,et al.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.

[6]  J. Bernstein,et al.  Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. , 2010, The New England journal of medicine.

[7]  W. Lumry,et al.  EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  M. Cicardi,et al.  Angioedema due to C1 inhibitor deficiency in 2010 , 2010, Internal and emergency medicine.

[9]  K. Bork,et al.  Economic costs associated with acute attacks and long-term management of hereditary angioedema. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  A. Kaplan,et al.  The bradykinin-forming cascade and its role in hereditary angioedema. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  T. Klingebiel,et al.  Pharmacokinetic analysis of human plasma–derived pasteurized C1‐inhibitor concentrate in adults and children with hereditary angioedema: a prospective study , 2010, Transfusion.

[12]  W. Pullman,et al.  Hypersensitivity Reactions Following Ecallantide Treatment for Acute Attacks of HAE , 2010 .

[13]  J. V. Van Sickels,et al.  Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[14]  Francesco Tedesco,et al.  Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. , 2009, The Journal of allergy and clinical immunology.

[15]  A. Bygum,et al.  Hereditary angio‐oedema in Denmark: a nationwide survey , 2009, The British journal of dermatology.

[16]  J. Bernstein,et al.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. , 2009, The Journal of allergy and clinical immunology.

[17]  M. Gobbi,et al.  Recombinant C1 inhibitor in brain ischemic injury , 2009, Annals of neurology.

[18]  T. Klingebiel,et al.  C1‐inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis , 2009, Transfusion.

[19]  T. Craig,et al.  Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. , 2009, Allergy and asthma proceedings.

[20]  G. Blohmé.  Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study. , 2009 .

[21]  H. Longhurst,et al.  Clinical Immunology Review Series: An approach to the patient with angio‐oedema , 2009, Clinical and experimental immunology.

[22]  K. Andersen,et al.  Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. , 2009, European journal of dermatology : EJD.

[23]  A. Bellatorre,et al.  Plasma biomarkers of acute attacks in patients with angioedema due to C1‐inhibitor deficiency , 2009, Allergy.

[24]  H. Farkas,et al.  Disease expression in women with hereditary angioedema. , 2008, American journal of obstetrics and gynecology.

[25]  H. Joller-jemelka,et al.  Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. , 2008, Journal of immunological methods.

[26]  A. Tordai,et al.  Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. , 2008, Molecular immunology.

[27]  K. Bork,et al.  Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema , 2008, Allergy.

[28]  H. Longhurst.  Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. , 2008, Current opinion in investigational drugs.

[29]  T. Klingebiel,et al.  Age-related Reference Ranges Of C1-inh Activity And Antigen Are Important For Early Diagnosis In Paediatric Patients With Hereditary Angioedema (hae) , 2008 .

[30]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  H. Farkas,et al.  Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. , 2007, The Journal of allergy and clinical immunology.

[32]  H. Farkas,et al.  Management of Hereditary Angioedema in Pediatric Patients , 2007, Pediatrics.

[33]  Lynda Schneider,et al.  Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. , 2007, The Journal of allergy and clinical immunology.

[34]  M. Mohammadi,et al.  An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio‐oedema , 2007, Clinical and experimental immunology.

[35]  Dongxu Liu,et al.  C1 inhibitor: biologic activities that are independent of protease inhibition. , 2007, Immunobiology.

[36]  H. Farkas,et al.  Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks , 2007, Transfusion.

[37]  P. Schlattmann,et al.  Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). , 2007, The Journal of allergy and clinical immunology.

[38]  H. Farkas,et al.  Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema , 2007 .

[39]  W. Sewell,et al.  Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. , 2007, Clinical immunology.

[40]  Z. Rónai,et al.  Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE). , 2007, Molecular immunology.

[41]  T. Craig,et al.  Fresh frozen plasma for the treatment of hereditary angioedema. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[42]  K. Khair,et al.  C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option , 2006, Clinical and experimental immunology.

[43]  M. Cicardi,et al.  Angioedema without urticaria: a large clinical survey , 2006, Canadian Medical Association Journal.

[44]  M. Levi,et al.  Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. , 2006, The Journal of allergy and clinical immunology.

[45]  A. Eckardt,et al.  Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency , 2006, The American Journal of Gastroenterology.

[46]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[47]  K. Bork,et al.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.

[48]  A. Eerenberg,et al.  A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.

[49]  D. Lomas.  Molecular mousetraps, α1-antitrypsin deficiency and the serpinopathies , 2005 .

[50]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[51]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[52]  A. Tordai,et al.  HAEdb: A novel interactive, locus‐specific mutation database for the C1 inhibitor gene , 2005, Human mutation.

[53]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[54]  K. Bork,et al.  Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. , 2003, Journal of the American Dental Association.

[55]  M. Cicardi,et al.  Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor Deficiencies , 2003, Medicine.

[56]  K. Bork,et al.  Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.

[57]  M. Gompels,et al.  Misdiagnosis of hereditary angio‐oedema type 1 and type 2 , 2003, The British journal of dermatology.

[58]  M. Cicardi,et al.  Bradykinin and the pathophysiology of angioedema. , 2003, International immunopharmacology.

[59]  K. Bork,et al.  Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.

[60]  M. Gompels,et al.  A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. , 2002, Journal of clinical pathology.

[61]  H. Farkas,et al.  Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema , 2001, The Lancet.

[62]  H. Farkas,et al.  Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema , 2001, European journal of gastroenterology & hepatology.

[63]  M. Kazatchkine,et al.  A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[64]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[65]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[66]  C. Hack,et al.  C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. , 2000, Pharmacological reviews.

[67]  M. Cicardi,et al.  Local bradykinin generation in hereditary angioedema. , 1999, The Journal of allergy and clinical immunology.

[68]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[69]  F. Rosen,et al.  A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.

[70]  A. Davis,et al.  Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. , 1997, Journal of immunology.

[71]  P. Mannucci,et al.  Activation of the coagulation cascade in C1-inhibitor deficiencies. , 1997, Blood.

[72]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[73]  F. Rosen,et al.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.

[74]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[75]  A. Sheffer,et al.  Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. , 1981, The Journal of allergy and clinical immunology.

[76]  M. Cicardi,et al.  C1-inhibitor concentrate for treatment of hereditary angioedema. , 1980, The New England journal of medicine.

[77]  D. Alling,et al.  Di George syndrome associated with glioma and two kinds of viral infection. , 1977 .

[78]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[79]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[80]  A. Davis.  The pathophysiology of hereditary angioedema. , 2005, Clinical immunology.

[81]  R. Wood,et al.  TREATMENT OF 193 EPISODES OF LARYNGEAL EDEMA WITH C1 INHIBITOR CONCENTRATE IN PATIENTS WITH HEREDITARY ANGIOEDEMA , 2002 .

[82]  M. Cicardi,et al.  Mechanisms of C1-inhibitor deficiency. , 2002, Immunobiology.

[83]  A. Davis.  Structure and function of C1 inhibitor. , 1989, Behring Institute Mitteilungen.

[84]  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access HAE international home therapy consensus , 2022 .

[85]  P. Keith,et al.  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access , 2022 .